SUBLINGUALES APOMORPHIN

European patent · EP2442650 · In force

Register entry

Publication number
EP2442650
Application number
EP10786915
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 11, 2010
Published
Apr 25, 2012
Granted
Aug 26, 2015
Protection ends at the latest
Jun 10, 2030
Next annual fee due
Jun 30, 2027
IPC classes
A61K 31/473 (2006.01)
A61K 31/44 (2006.01)
A01N 43/42 (2006.01)
A61K 47/02 (2006.01)
A61P 15/10 (2006.01)
A61P 25/16 (2006.01)
Priority
US 186445 P 12.06.2009
PCT application
PCT/US2010/038336 11.06.2010
PCT publication
WO2010/144817 16.12.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Sep 15, 2025

    Merged

    Owner
    Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA 01752, USA → Sumitomo Pharma America, Inc., 84 Waterford Drive, Marlborough, MA 01752, USA

    Published in Swissreg on 15.09.2025

  3. Aug 19, 2025

    Agent’s address changed

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 106, 8001 Zürich → Stolmár & Partner Intellectual Property GmbH, Bahnhofstrasse 11, 6210 Sursee

    Published in Swissreg on 19.08.2025

  4. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  5. Apr 16, 2025

    Change

    Published in Swissreg on 16.04.2025

  6. Jul 4, 2024

    Change

    Published in Swissreg on 04.07.2024

  7. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  8. Mar 29, 2023

    Change

    Published in Swissreg on 29.03.2023

7 earlier entries
  1. Nov 9, 2022

    Address changed

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l, Rue du Cendrier 15, CP 1489, 1201 Genève → Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 106, 8001 Zürich

    Published in Swissreg on 09.11.2022

  2. Jul 6, 2022

    Change

    Published in Swissreg on 06.07.2022

  3. Aug 9, 2018

    Transferred

    Owner
    Cynapsus Therapeutics Inc., 828 Richmond Street, W, Toronto, ON M6J 1C9, Canada → Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA 01752, USA

    Published in Swissreg on 09.08.2018

  4. Oct 14, 2017

    Address changed

    Representative
    Stolmár & Partner, Intellectual Property S.à.r.l., 18, Avenue Louis-Casaï, 1209 Genf → Stolmár & Partner Intellectual Property S.à.r.l, Rue du Cendrier 15, CP 1489, 1201 Genève

    Published in Swissreg on 14.10.2017

  5. Jan 16, 2016

    Address changed

    Representative
    Stolmár & Partner, Patent- und Markenanwälte, Seefeldstrasse 69, 8008 Zürich → Stolmár & Partner, Intellectual Property S.à.r.l., 18, Avenue Louis-Casaï, 1209 Genf

    Published in Swissreg on 16.01.2016

  6. Nov 25, 2015

    Agent entered

    Representative
    Stolmár & Partner, Patent- und Markenanwälte, Seefeldstrasse 69, 8008 Zürich

    Published in Swissreg on 25.11.2015

  7. Aug 26, 2015

    Granted

    Published in Swissreg on 26.08.2015

Parties

Holder

Sumitomo Pharma America, Inc.

84 Waterford Drive, Marlborough, MA 01752, US

Agent

Stolmár & Partner Intellectual Property GmbH

Bahnhofstrasse 11, 6210 Sursee

Inventor

GIOVINAZZO, Anthony, John

Oakville ON L6H 0B9, CA

HEDDEN, David, Bruce

Ann Arbor MI 48103, US

DE SOMER, Marc, L.

Ann Arbor, Michigan 48103, US

BRYSON, Nathan, John

Toronto ON M4W 2V8, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.